 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
Date |
Open |
High |
Low |
Close |
Volume |
03/17/2023 |
$18.50 |
$18.50 |
$18.50 |
$18.50 |
100 | 03/20/2023 |
$18.28 |
$18.48 |
$17.84 |
$17.84 |
1.30K | 03/21/2023 |
$18.29 |
$18.68 |
$18.29 |
$18.68 |
300 | 03/22/2023 |
$18.12 |
$18.52 |
$18.10 |
$18.10 |
200 | 03/23/2023 |
$18.38 |
$18.38 |
$18.25 |
$18.25 |
200 |
 |
PowerShares S&P 500 Downside Hedged Portfolio (the fund) is an open-end management investment company. The fund seeks to achieve its investment objective by using a quantitative, rules-based strategy designed to provide returns that correspond to the performance of the S&P 500® Dynamic VEQTOR Index (the "Benchmark"). The Benchmark is comprised of up to three types of components at any given time: an equity component, represented by the S&P 500® Index; a volatility component, represented by the VIX Futures Index; and cash. As of Oct 31 2013, the Fund's total assets were $89,753,840 and the Fund's investment portfolio was valued at $84,103,379. | |
 |

Loncar China Biopharma Etf (CHNA) has the following price history information. Looking back at CHNA historical stock prices for the last five trading days, on March 17, 2023, CHNA opened at $18.50, traded as high as $18.50 and as low as $18.50, and closed at $18.50. Trading volume was a total of 100 shares. On March 20, 2023, CHNA opened at $18.28, traded as high as $18.48 and as low as $17.84, and closed at $17.84. Trading volume was a total of 1.30K shares. On March 21, 2023, CHNA opened at $18.29, traded as high as $18.68 and as low as $18.29, and closed at $18.68. Trading volume was a total of 300 shares. On March 22, 2023, CHNA opened at $18.12, traded as high as $18.52 and as low as $18.10, and closed at $18.10. Trading volume was a total of 200 shares. On March 23, 2023, CHNA opened at $18.38, traded as high as $18.38 and as low as $18.25, and closed at $18.25. Trading volume was a total of 200 shares.
CHNA Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Loncar China Biopharma Etf shares, starting with a $10,000 purchase of CHNA, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
08/15/2018 |
|
End date: |
03/23/2023 |
|
Start price/share: |
$23.80 |
|
End price/share: |
$18.25 |
|
Starting shares: |
420.17 |
|
Ending shares: |
473.52 |
|
Dividends reinvested/share: |
$3.23 |
|
Total return: |
-13.56% |
|
Average Annual Total Return: |
-3.11% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$8,645.86 |
|
Years: |
4.61 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
08/15/2018 |
|
End date: |
03/23/2023 |
|
Start price/share: |
$23.80 |
|
End price/share: |
$18.25 |
|
Dividends collected/share: |
$3.23 |
|
Total return: |
-9.74% |
|
Average Annual Total Return: |
-2.20% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$9,026.22 |
|
Years: |
4.61 |
|
|
 |
Date |
Close |
03/17/2023 | $18.50 | 03/20/2023 | $17.84 | 03/21/2023 | $18.68 | 03/22/2023 | $18.10 | 03/23/2023 | $18.25 |
|
 |